Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Novo Nordisk, the Danish pharma company behind several GLP-1RA drugs (including Ozempic/Wegovy and Saxenda) grew its sales by over 30% in 2023, and its share price rose by over 70% in the last year, making it the most valuable European company by market capitalization
Scientists still dont know whether the drugs directly improve ADHD symptoms
- Naturally increases GLP-1 levels
The skeptics capitulate, the true believers double down, the estimates untether from reality
US$ 29.51
US$ 24.59
US$ 29.81
US$ 21.52
